Immunogenic HBc chimer particles having enhanced stability

Details for Australian Patent Application No. 2001285452 (hide)

Owner Celldex Therapeutics Limited

Inventors Birkett, Ashley J.

Agent Griffith Hack

Pub. Number AU-B-2001285452

PCT Pub. Number WO02/14478

Priority 60/226,867 22.08.00 US; 60/225,843 16.08.00 US; 09/930,915 15.08.01 US

Filing date 16 August 2001

Wipo publication date 25 February 2002

Acceptance publication date 2 November 2006

International Classifications

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

C07K 14/02 (2006.01) Peptides having more than 20 amino acids

C07K 14/09 (2006.01) Peptides having more than 20 amino acids

C07K 14/15 (2006.01) Peptides having more than 20 amino acids

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C07K 14/445 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/50 (2006.01) Peptides having more than 20 amino acids

Event Publications

13 July 2006 Assignment before Grant

  Apovia, Inc. The application has been assigned to Celldex Therapeutics Limited 2002

2 November 2006 Application Accepted

  Published as AU-B-2001285452

1 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001285453

2001285451